Analyst Recommendations

BMO Capital analyst issues PERFORM recommendation for OKTA on February 29, 2024 12:45PM ET. The previous analyst recommendation was Perform.OKTA was trading at $104.13 at issue of the...

February 29, 2024   OKTA -0.38%

JMP Securities analyst issues MARKET PERFORM recommendation for OKTA on February 29, 2024 12:45PM ET. The previous analyst recommendation was Market Perform.OKTA was trading at $104.1241 at issue...

February 29, 2024   OKTA -0.38%

Stephens analyst issues BUY recommendation for ALKT on February 29, 2024 10:00AM ET. The previous analyst recommendation was Buy.ALKT was trading at $24.035 at issue of the analyst...

February 29, 2024   ALKT 0.96%

UBS analyst issues MARKET PERFORM recommendation for URBN on February 29, 2024 09:00AM ET. The previous analyst recommendation was Market Perform.URBN was trading at $43.13 at issue of...

February 29, 2024   URBN -4.59%

UBS analyst issues NEUTRAL recommendation for PSTG on February 29, 2024 10:40AM ET. The previous analyst recommendation was Neutral.PSTG was trading at $51.455 at issue of the analyst...

February 29, 2024   PSTG 3.32%

Telsey Advisory analyst issues BUY recommendation for HLLY on February 29, 2024 10:01AM ET. The previous analyst recommendation was Buy.HLLY was trading at $4.305 at issue of the...

February 29, 2024   HLLY 0.95%

H.C. Wainwright analyst issues BUY recommendation for ADMA on February 29, 2024 10:01AM ET. The previous analyst recommendation was Buy.ADMA was trading at $5.515 at issue of the...

February 29, 2024   ADMA -0.31%

Cantor Fitzgerald analyst issues UNDERPERFORM recommendation for ADMA on February 29, 2024 10:01AM ET. The previous analyst recommendation was Underperform.ADMA was trading at $5.515 at issue of the...

February 29, 2024   ADMA -0.31%

UBS analyst issues OUTPERFORM recommendation for CRM on February 29, 2024 10:40AM ET. The previous analyst recommendation was Outperform.CRM was trading at $303.75 at issue of the analyst...

February 29, 2024   CRM 1.00%

Guggenheim analyst issues UNDERPERFORM recommendation for MRSN on February 29, 2024 11:00AM ET. The previous analyst recommendation was Underperform.MRSN was trading at $5.796 at issue of the analyst...

February 29, 2024   MRSN -0.54%